POTENTIAL THERAPEUTIC ROLE OF CREATINE SUPPLEMENTATION IN DOXORUBICIN-INDUCED CARDIOTOXICITY

被引:0
|
作者
Sharif, Salaheddin
Olson, Thomas P.
Hydock, David
机构
[1] Mayo Clin, Rochester, MN USA
[2] Univ Northern Colorado, Greeley, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1275-222
引用
收藏
页码:1806 / 1806
页数:1
相关论文
共 50 条
  • [41] Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity
    Wu, Lin
    Wang, Litao
    Du, Yuxin
    Zhang, Yingmei
    Ren, Jun
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (01) : 34 - 49
  • [42] Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
    Mohammad Sheibani
    Yaser Azizi
    Maryam Shayan
    Sadaf Nezamoleslami
    Faezeh Eslami
    Mohammad Hadi Farjoo
    Ahmad Reza Dehpour
    Cardiovascular Toxicology, 2022, 22 : 292 - 310
  • [43] Subclinical doxorubicin-induced cardiotoxicity update: role of neutrophils and endothelium
    Todorova, Valentina K.
    Wei, Jeanne Y.
    Makhoul, Issam
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (09): : 4070 - 4091
  • [44] DOXORUBICIN-INDUCED CARDIOTOXICITY - GENDER DIFFERENCES AND A PROTECTIVE ROLE OF AMPK
    Mihalikova, Dominika
    Czarnowski, Alexander
    Oelze, Matthias
    Ubbens, Henning
    Strohm, Lea
    Molitor, Michael
    Muenzel, Thomas
    Daiber, Andreas
    Stamm, Paul
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 218 : 34 - 34
  • [45] Doxorubicin-induced cardiotoxicity - gender differences and a protective role of AMPK
    Stamm, Paul
    Mihalikova, Dominika
    Czarnowski, Alexander
    Oelze, Matthias
    Strohm, Lea
    Ubbens, Henning
    Molitor, Michael
    Muenzel, Thomas
    Daiber, Andreas
    Lurz, Philipp
    INNERE MEDIZIN, 2024, 65 : S129 - S130
  • [46] The role of ivabradine in doxorubicin-induced cardiotoxicity: exploring of underlying argument
    Hayder M. Al-kuraishy
    Hajer K. Issa
    Ali I. Al-Gareeb
    Maisra M. El-Bouseary
    Amal Youssef
    Ahmed Shaban Abdelaziz
    Hesham Ahmed Khalifa
    Gaber El-Saber Batiha
    Inflammopharmacology, 2022, 30 : 2441 - 2446
  • [47] Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
    Sheibani, Mohammad
    Azizi, Yaser
    Shayan, Maryam
    Nezamoleslami, Sadaf
    Eslami, Faezeh
    Farjoo, Mohammad Hadi
    Dehpour, Ahmad Reza
    CARDIOVASCULAR TOXICOLOGY, 2022, 22 (04) : 292 - 310
  • [48] Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options
    Yarmohammadi, Fatemeh
    Karbasforooshan, Hedyieh
    Hayes, A. Wallace
    Karimi, Gholamreza
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (10) : 2003 - 2011
  • [49] Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options
    Fatemeh Yarmohammadi
    Hedyieh Karbasforooshan
    A. Wallace Hayes
    Gholamreza Karimi
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 2003 - 2011
  • [50] Protective role of Nd1 in doxorubicin-induced cardiotoxicity
    Fujimura, L
    Matsudo, Y
    Kang, M
    Takamori, Y
    Tokuhisa, T
    Hatano, M
    CARDIOVASCULAR RESEARCH, 2004, 64 (02) : 315 - 321